BIO INNOVATION NOTES
defines successful applications of single-use systems versus
unsuccessful ones, and so far at least, most of the focus has
been on physical connections such as tubing and connectors, giving them a leg up on other products.
Given healthy penetration of disposable connectors —
and growing end user desire for innovation — it's likely that
the industry will continue to see a number of innovations
in this area. Vendors will need to consider standardizing
these devices to satisfy end user demand. With disposable
devices continuing to make inroads into commercial biomanufacturing, we can expect that the importance of connectors and clamps will only rise over time. These devices
enable the shift towards disposable usage, and innovation
should continue as vendors recognize that their use (and
standardization) is crucial in the continued maturation of
the disposables market.
Figure 1: Selected New Product Development Areas Of Interest
U.S. vs. Western Europe vs. Rest Of The World
47.7%
45.7%
Disposable Products: bags, connectors, etc.
26.1%
Disposable Products: probes, sensors, etc.
Disposable Products: bioreactors
U.S. Only
31.4%
21.7%
Western Europe Only
Rest Of The World
46.5%
31.4%
26.1%
38.4%
34.9%
Disposable Products: purification
17.4%
42.9%
Figure 2: Single Use/Disposables Standardization Factors
"In my opinion, single use/disposables vendors need to work harder to standardize."
Very Important
Important
Connector Compatability
47.8%
36.7%
*The remaining 15.5% indicated
"unimportant or don't know."
Survey Methodology: The 2013 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production is an evaluation
by BioPlan Associates, Inc. that yields a composite view of and trend analysis from 300 to 400 responsible individuals at biopharmaceutical
manufacturers and CMOs in 29 countries. The respondents also include more than 185 direct suppliers of materials, services, and equipment
to this industry. Each year the study covers issues including new product needs, facility budget changes, current capacity, future capacity
constraints, expansions, use of disposables, trends and budgets in disposables, trends in downstream purification, quality management and
control, hiring, and employment. The quantitative trend analysis provides details and comparisons of production by biotherapeutic developers
and CMOs. It also evaluates trends over time and assesses differences in the world's major markets in the U.S. and Europe.
If you want to learn more about the report, please go to bioplanassociates.com.
22
LifeScienceLeader.com
August 2013